Come up with a name for your new list and we'll add to it:
Alvine Pharmaceuticals raised a round of funding on February 24, 2010. Investors include
Qualifying Therapeutic Discovery Project.
Alvine Pharmaceuticals is a clinical-stage, specialty biopharmaceutical company focused on the development of biologics targeting autoimmune and inflammatory diseases, including celiac disease. Alvine…